Frontiers in Oncology Abbreviation (ISO4)

Frontiers in Oncology (ISO4) Standard Journal Abbreviation

Front. Oncol. (Front Oncol)


Frontiers in Oncology - Abbreviation - Journals usually have long names, such as (Frontiers in Oncology). It is hard to list them in databases with such long names so they’re usually shortened to aid in storing data. These shortened names are known as journal abbreviations. Journal abbreviations are shortened from the Journal title. An example of a Frontiers in Oncology abbreviation is Front. Oncol. (Front Oncol).

The use of standardized abbreviations is important to get correct and corroborated scientific and technical citations.

Abbreviation of Frontiers in Oncology

The official abbreviation of the Frontiers in Oncology is Front. Oncol. it is a standardized way to abstract, index, and reference a particular journal according to ISO 4. For example, if you’re looking for a scientific journal that particularly publishes research related to in / then you can gather the required information from Frontiers in Oncology.

This abbreviation of the title meets all the criteria issued by ISO4 for choosing journal title abbreviations.

The official abbreviation of the Frontiers in Oncology is Front. Oncol.


Frontiers in Oncology - Abbreviation Details


Journal Name Frontiers in Oncology
Journal Abbreviation Front. Oncol. (Front Oncol)
Journal Online 2234-943X (2234943X)
Impact Factor Frontiers in Oncology Impact Factor
CiteScore Frontiers in Oncology CiteScore
Acceptance Rate Frontiers in Oncology Acceptance Rate
SCImago Journal Rank Frontiers in Oncology SJR (SCImago Journal Rank)

ISO4 and LTWA

List of Title Word Abbreviations or LTWA is standard abbreviations for words commonly found in serial titles. LTWA includes has more than 56,000 words and their abbreviations in about 65 languages, it is a vast database. These abbreviated words serve as the basis for constituting “abbreviated key titles” published in the ISSN Register. So might consist of words from LTWA that are formed according to ISO4 by ISSN.

The International Organization for Standardization (ISO) has appointed the ISSN (International Standard Serial Number) International Centre as the registration authority for ISO 4. ISO 4 (Information and documentation – Rules for the abbreviation of title words and titles of publications) is an international standard that marks a static system for the abbreviation of serial publication titles. According to ISO4, terms are abbreviated according to LTWA. It is a list that is filled with all the uniform abbreviations used for words in scientific excerpts. It is based on ISO 4.

International Standard for Serial Numbers provides guidelines for abbreviating titles of serials and, if required, non-serial documents by using alphabets from languages like Latin, Cyrillic, and Greek.

Frontiers in Oncology - Abbreviation

How to abbreviate Journal Titles

  • Omit articles, conjunctions, and prepositions.
  • Capitalize all abbreviated words.
  • Only abbreviate the title proper.
  • Single-word titles and titles in languages, such as Chinese, Japanese, and Korean that use characters should not be abbreviated.
  • Single-syllable words and words of 5 or fewer letters in singular form are not usually abbreviated as it is not required.
  • Words in the can also be abbreviated by the help of contraction (omission of a few internal letters).

Frontiers in Oncology

Frontiers in Oncology publishes rigorously peer-reviewed research advancing our knowledge of cancer epidemiology, molecular pathways, diagnosis and imaging, personalized therapeutics, and novel treatment and management strategies. Field Chief Editor Giuseppe Giaccone at Weill Cornell Medicine, Cornell University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific advancement and impactful discoveries in the field of oncology to researchers, academics, clinicians, and the public worldwide. Frontiers in Oncology welcomes contributions in the various domains of cancer research, from basic research to clinical studies. The journal is composed of different speciality sections and authors are kindly requested to consider the specific requirements of the most adequate speciality for their submission. Most notably, manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology. Frontiers in Oncology is a member of the Committee on Publication Ethics. more...









Related Journals